Psychopharmacology B

Selective Serotonin Re-uptake Inhibitors (SSRIs)

2 Serotonin-Noradrenaline Re-uptake Inhibitors (SNRIs)

2 Tricyclic Antidepressants (TCAs)

2 Monoamine Oxidase Inhibitors (MAOIs)

Neurotransmitters targeted by
SSRIs, SNRIs, TCAs and MAOIs

Side-effects of Antidepressants

different side-effects between the anti-depressant groups

Signs and symptoms of ‘serotonin syndrome’ (SS)

The Hunter Serotonin Toxicity Criteria

MAOIs and foods and drinks that are contra-indicated when on these antidepressants

Clinical conditions that mood stabilisers can be prescribed for

2 mood stabilisers

Serum concentrations for the therapeutic range of Lithium

Serum concentration level of Lithium that is considered toxic

Signs and symptoms of Lithium Toxicity

Benzodiazepines (at least 2)

Recommendations for duration of use of benzodiazepines

clinical conditions that benzodiazepines can be prescribed for

withdrawal symptoms (at least 6) of benzodiazepines

Read up on the NMC (2010) Standards for Medicines Management:

Section 4 (Standard 8) Standards for practice of administration of medicines